Related Experiment Videos
[Prognostic evaluation of human solid tumors by immunohistology]
P Delvenne1, C Delvenne, V Fridman
1Département d'Anatomie pathologique, Université de Liège.
Revue Medicale De Liege
|November 5, 1999
Summary
This study evaluates novel tumor markers for common cancers like breast and prostate. An immunohistologic technique was developed to analyze these prognostic markers, aiding clinical decisions.
Area of Science:
- Oncology
- Pathology
- Molecular Diagnostics
Context:
- Frequent solid tumors including breast, colon, and prostate cancers present a significant clinical challenge.
- Accurate prognostic markers are crucial for effective cancer patient management and treatment planning.
- The integration of pathology and laboratory results is vital for advancing oncologic care.
Purpose:
- To assess the clinical utility of novel tumor markers in prevalent solid malignancies.
- To develop and implement an immunohistologic technique for analyzing selected prognostic markers.
- To provide clinicians with accessible tools for interpreting laboratory findings.
Summary:
- The project focuses on evaluating new tumor markers for common solid tumors such as breast, colon, and prostate cancers.
- Potential prognostic markers were identified from existing literature and analyzed using a newly developed immunohistologic technique.
- The study discusses the role of pathology in oncology, details the analyzed markers, and introduces a website for clinical application.
Impact:
- This research aims to improve the prognostic accuracy for patients with common solid tumors.
- The developed immunohistologic technique offers a standardized method for marker analysis.
- The accompanying website facilitates the practical application of laboratory results in clinical oncology settings.